精胺
基因沉默
RNA干扰
小干扰RNA
体内
离体
基因敲除
体外
转染
化学
基因传递
核糖核酸
细胞生物学
分子生物学
生物物理学
生物化学
生物
基因
生物技术
酶
作者
Friederike Adams,Christoph M. Zimmermann,Domizia Baldassi,Thomas M. Pehl,Philipp Weingarten,Iris Kachel,Moritz Kränzlein,David C. Jürgens,Peter Braubach,Ioannis Alexopoulos,Małgorzata Wygrecka,Olivia M. Merkel
出处
期刊:Small
[Wiley]
日期:2023-12-21
卷期号:20 (22): e2308775-e2308775
被引量:27
标识
DOI:10.1002/smll.202308775
摘要
RNA interference (RNAi) is an efficient strategy to post-transcriptionally silence gene expression. While all siRNA drugs on the market target the liver, the lung offers a variety of currently undruggable targets, which can potentially be treated with RNA therapeutics. To achieve this goal, the synthesis of poly(spermine acrylamides) (P(SpAA) is reported herein. Polymers are prepared via polymerization of N-acryloxysuccinimide (NAS) and afterward this active ester is converted into spermine-based pendant groups. Copolymerizations with decylacrylamide are employed to increase the hydrophobicity of the polymers. After deprotection, polymers show excellent siRNA encapsulation to obtain perfectly sized polyplexes at very low polymer/RNA ratios. In vitro 2D and 3D cell culture, ex vivo and in vivo experiments reveal superior properties of amphiphilic spermine-copolymers with respect to delivery of siRNA to lung cells in comparison to commonly used lipid-based transfection agents. In line with the in vitro results, siRNA delivery to human lung explants confirm more efficient gene silencing of protease-activated receptor 2 (PAR2), a G protein-coupled receptor involved in fibrosis. This study reveals the importance of the balance between efficient polyplex formation, cellular uptake, gene knockdown, and toxicity for efficient siRNA delivery in vitro, in vivo, and in fibrotic human lung tissue ex vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI